Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Jeffrey Conroy
Introduction
Jeffrey Conroy, an inventive spirit hailing from Williamsville, NY, is making significant strides in the realm of personalized medicine. With a total of two patents to his name, Conroy's innovative methods are poised to transform cancer therapy through more tailored treatment approaches.
Latest Patents
Conroy's latest patents focus on advancing immunotherapy techniques. The first patent describes "Methods and systems for determining personalized therapies," which involves generating an immune score through a comprehensive analysis of tumor-infiltrating lymphocytes, T-cell receptor signaling, and mutation burden. This innovative method allows for a deeper understanding of a patient's immune response to cancer.
The second patent, titled "Methods and systems for assessing proliferative potential and resistance to immune checkpoint blockade," outlines a method for characterizing tumor response to immune checkpoint therapy. This includes obtaining tumor tissue, measuring gene markers related to cell proliferation, and predicting the tumor's reaction to treatment. Such advancements could enable clinicians to tailor therapies that align with individual tumor profiles.
Career Highlights
At present, Jeffrey Conroy is associated with Omniseq, Inc., a leading company in the field of precision medicine. His role at Omniseq allows him to work on cutting-edge technologies that address critical challenges in cancer treatment, aiming to improve patient outcomes through personalized therapy approaches.
Collaborations
Conroy collaborates with esteemed colleagues, including Carl Morrison and Sarabjot Pabla. Together, they work to further the field of immunotherapy, sharing insights and expertise that help drive innovations and advancements in cancer treatment.
Conclusion
Jeffrey Conroy's inventive contributions to the field of personalized cancer therapies are noteworthy. With a deep commitment to improving patient care through innovative methods, Conroy continues to play a pivotal role in the evolution of cancer treatment, impacting the lives of many and paving the way for future advancements in medical science.